BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 25432572)

  • 1. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.
    Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML
    J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.
    Ji J; Greenberg ML
    J Inherit Metab Dis; 2022 Jan; 45(1):60-71. PubMed ID: 34626131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cardiolipin in Cardiovascular Health.
    Shen Z; Ye C; McCain K; Greenberg ML
    Biomed Res Int; 2015; 2015():891707. PubMed ID: 26301254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin.
    Li Y; Lou W; Grevel A; Böttinger L; Liang Z; Ji J; Patil VA; Liu J; Ye C; Hüttemann M; Becker T; Greenberg ML
    J Biol Chem; 2020 Aug; 295(33):11928-11937. PubMed ID: 32636300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
    Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
    Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
    Mejia EM; Cole LK; Hatch GM
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.
    Abe M; Hasegawa Y; Oku M; Sawada Y; Tanaka E; Sakai Y; Miyoshi H
    J Biol Chem; 2016 Jul; 291(30):15491-502. PubMed ID: 27268057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome.
    Joshi A; Gohil VM
    Hum Mol Genet; 2023 Dec; 32(24):3353-3360. PubMed ID: 37721533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
    Gaspard GJ; McMaster CR
    Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia.
    Chowdhury A; Aich A; Jain G; Wozny K; Lüchtenborg C; Hartmann M; Bernhard O; Balleiniger M; Alfar EA; Zieseniss A; Toischer K; Guan K; Rizzoli SO; Brügger B; Fischer A; Katschinski DM; Rehling P; Dudek J
    Cell Rep; 2018 Oct; 25(3):561-570.e6. PubMed ID: 30332638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling.
    Baile MG; Whited K; Claypool SM
    Mol Biol Cell; 2013 Jun; 24(12):2008-20. PubMed ID: 23637464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model.
    Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular functions of cardiolipin in yeast.
    Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML
    Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.